MAM-2201 (analytically confirmed) intoxication after "synthacaine" consumption

Annals of Emergency Medicine

Volumn 64, Issue 6, 2014, Pages 629-632

  Lonati, Davide ^a   Buscaglia, Eleonora ^a   Papa, Pietro ^b   Valli, Antonella ^b   Coccini, Teresa ^a   Giampreti, Andrea ^a   Petrolini, Valeria Margherita ^a   Vecchio, Sarah ^a   Serpelloni, Giovanni ^c   Locatelli, Carlo Alessandro ^a  

^a IRCCS   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Presidency of the Council of Ministers ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALANINE AMINOTRANSFERASE; BENZOCAINE; BENZOYLECGONINE; C REACTIVE PROTEIN; CANNABINOID RECEPTOR AGONIST; COCAINE; CREATINE KINASE; CREATININE; DIAZEPAM; ELECTROLYTE; GLUCOSE; MAM 2201; TROPONIN; UNCLASSIFIED DRUG; 1-(5-FLUOROPENTYL)-3-(4-METHYL-1-NAPHTHOYL)INDOLE; INDOLE DERIVATIVE; NAPHTHALENE DERIVATIVE; STREET DRUG;

ADULT; ARTERIAL GAS; ARTICLE; BODY TEMPERATURE; BORDERLINE HYPERTENSION; CASE REPORT; CHEMICAL STRUCTURE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG INTOXICATION; DYSPNEA; EMERGENCY WARD; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MASS FRAGMENTOGRAPHY; TACHYCARDIA; THORAX PAIN; XEROSTOMIA; CHEMISTRY; YOUNG ADULT;

BENZOCAINE; CANNABINOID RECEPTOR AGONISTS; HUMANS; INDOLES; MALE; NAPHTHALENES; STREET DRUGS; YOUNG ADULT;

EID: 84914112407     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2014.01.007     Document Type: Article

References (17)

1. Benzo-fury.me [Internet]. Available at: http://www.benzofury.me/. Accessed October 16, 2013.
2. A.R. Rigon, and R.N. Takahashi Stimulant activities of dimethocaine in mice: reinforcing and anxiogenic effects Psychopharmacology 127 1996 323 327
3. P. Kavanagh, D. Angelov, and J. O'Brien The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine™) Drug Test Anal 5 2013 247 253
4. K. Simolka, R. Lindigkeit, and H.M. Schiebel Analysis of synthetic cannabinoids in "spicelike" herbal highs: snapshot of the German market in summer 2011 Anal Bioanal Chem 404 2012 157 171
5. R. Kronstrand, M. Roman, and M. Andersson Toxicological findings of synthetic cannabinoids in recreational users J Anal Toxicol 37 2013 534 541
6. C. Manera, T. Tuccinardi, and A. Martinelli Indoles and related compounds as cannabinoid ligands Mini Rev Med Chem 8 2008 370 387
7. D. McQuade, S. Hudson, and P.I. Dargan First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201 Eur J Clin Pharmacol 69 2013 373 376
8. wiki.bluelight.ru [Internet]. Available at: http://wiki.bluelight.ru/index.php/MAM-2201. Accessed February 11, 2013.
9. A. Derungs, A.E. Schwaninger, and G. Mansella Symptoms, toxicities, and analytical results for a patient after smoking herbs containing the novel synthetic cannabinoid MAM-2201 Forensic Toxicol 31 2013 164 171
10. P.K. Narang, G. Bird, and W.G. Crouthamel High-performance liquid chromatographic assay for benzocaine and p-aminobenzoic acid including preliminary stability data J Pharm Sci 69 1980 1384 1387
11. R.J.E. Grouls, E. Machielsen, and H.H.M. Korsten Capillary gas chromatographic method for the determination of n-butyl-p-aminobenzoate and lidocaine in plasma samples J Chromathogr B 673 1995 51 57
12. T.J. Moore, C.S. Walsh, and M.R. Cohen Reported adverse event cases of methemoglobinemia associated with benzocaine products Arch Intern Med 164 2004 1192 1196
13. A. Chakladar, J.W. Willers, and E. Pereskokova White powder, blue patient: methaemoglobinaemia associated with benzocaine-adulterated cocaine Resuscitation 81 2010 138 139
14. G. Serpelloni, C. Rimondo, and D. Candio Drugs on the net. Results of a survey on the Italian Web Ital J Addict 2 2012 13 18
15. D. Lonati, A. Giampreti, and V. Petrolini Clinical identification and analytical confirmation of new synthetic cannabinoids poisonings in Italy: role of the Pavia Poison Centre in the National Early Warning System for drugs of abuse Clin Toxicol 49 2011 199
16. J. Lapoint, L.P. James, and C.L. Moran Severe toxicity following synthetic cannabinoid ingestion Clin Toxicol 49 2011 760 764
17. A. Mir, A. Obafemi, and A. Young Myocardial infarction associated with use of the synthetic cannabinoid K2 Pediatrics 128 2011 e1622 e1627